Latest benign neoplasms Stories
Uterine leiomyomata, or fibroids, are benign tumors that nevertheless affect the health of millions of women. They may cause, for instance, pain, bleeding and infertility. Fibroids are also the most common reason for a hysterectomy; for example, some 8,000 hysterectomies are made in Finland each year. Scientists at the Academy of Finland's Centre of Excellence in Cancer Genetics Research have identified the molecular mechanisms underlying the onset of common leiomyomata. The results of...
Women who had sufficient amounts of vitamin D were 32 percent less likely to develop fibroids than women with insufficient vitamin D, according to a study from researchers at the National Institutes of Health. Fibroids, also known as uterine leiomyomata, are noncancerous tumors of the uterus. Fibroids often result in pain and bleeding in premenopausal women, and are the leading cause of hysterectomy in the United States. The study of 1,036 women, aged 35-49, living in the Washington,...
Fibroids Miracle is a new fibroids treatment method designed by Amanda Leto, who promises to help people get rid of fibroids permanently and naturally. A full Fibroids Miracle review on the site Vkool.com shows whether or not the method is safe for patients to follow. Seattle, Wa (PRWEB) April 03, 2013 Fibroids Miracle is a brand new fibroids treatment method created by Amanda Leto, who claims to help sufferers get rid of uterine fibroids quickly. This program does not contain...
LIVERMORE, Calif., April 1, 2013 /PRNewswire/ -- Halt Medical, Inc. announced today initial commercialization results for the Acessa System and additional launch plans. "We are grateful and encouraged that virtually all our clinical trial sites expressed an interest in launching the Acessa Procedure. As of this past week, all four of our initial launch sites have purchased and performed procedures," said Jeffrey M. Cohen, Halt Medical CEO. He added, "This is testimony to the proven...
STUDY WILL EVALUATE SIX MONTHS OF TREATMENT IN 280 SUBJECTS SAN DIEGO, March 27, 2013 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated. Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist, in development by AbbVie for the treatment of uterine fibroids and endometriosis. Neurocrine and AbbVie entered into a collaboration and license...
LIVERMORE, Calif., March 12, 2013 /PRNewswire/ -- Halt Medical, Inc. announced that Dr. Jay M. Berman, M.D., FACOG, has performed the first commercial Acessa Procedure in the United States. The procedure is used for the treatment of uterine fibroids. Dr. Berman performed the procedure at the Berry Surgery Center in Farmington Hills, MI, an outpatient facility affiliated with the Detroit Medical Center's DMC Sinai-Grace Hospital. "We are extremely happy that Dr. Berman, the Wayne...
IRVINGTON, N.Y., Feb. 21, 2013 /PRNewswire/ -- MELA Sciences, Inc. (NASDAQ: MELA). Despite alarming increases in skin cancer rates in the U.S., only 24% of American adults have had a skin check by a dermatologist. This statistic is one of several important findings from a survey conducted online by Harris Interactive® that reveals insights into behaviors regarding skin cancer detection and illustrates the urgency around improved preventative care. The study was conducted on behalf...
LIVERMORE, Calif., Feb. 11, 2013 /PRNewswire/ -- Halt Medical, Inc. announced today that on January 18, 2013, COFEPRIS, a division within the Mexican Ministry of Health (Secretaria de Salud) responsible for medical device oversight, issued registration for the Acessa System to treat symptomatic uterine fibroids. "Mexico is the second largest market for medical devices in Latin America," said Jeffrey Cohen, Halt's Chief Executive Officer. "We are very excited to have the opportunity...
Fibroids Miracle is the latest e-book created by Amanda Leto, who promises to give women the fibroid treatment to help them eliminate fibroid naturally. A full Fibroids Miracle review on the site HealthReviewCenter.com shows if the e-book is helpful for people to buy. Seattle, Wa (PRWEB) February 03, 2013 Fibroids Miracle is the new treatment method developed by Amanda Leto, who claims to provide female with the fibroid treatment that helps them get rid of fibroids naturally and...
LIVERMORE, Calif., Jan. 9, 2013 /PRNewswire/ -- Halt Medical, Inc. introduced today a team to drive commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids. "It gives me great pleasure to introduce Rodney Marcy as our Senior Vice President of Sales and Marketing," said Jeffrey Cohen, Halt's Chief Executive Officer. "Rodney has extensive commercial experience in the medical device field, and women's health sector. This will be instrumental...
